Iguatemi (B3: IGTI11) net income
Iguatemi reported a net profit of BRL 582.5m for fiscal 2025, 45.7% more than in fiscal 2024 (BRL 399.8m). Its net margin was 39.2%.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin |
|---|---|---|---|
| 2025 | BRL 582.5m | +45.7% | 39.2% |
| 2024 | BRL 399.8m | +31.2% | 32.3% |
| 2023 | BRL 304.7m | +3,926.3% | 26.3% |
| 2022 | BRL 7.6m | −96.8% | 0.7% |
| 2021 | BRL 239.0m | +212.4% | 27.9% |
| 2020 | BRL 76.5m | −40.5% | 11.3% |
| 2019 | BRL 128.7m | +16.8% | 17.0% |
| 2018 | BRL 110.2m | +43.2% | 15.2% |
| 2017 | BRL 76.9m | +256.6% | 11.1% |
| 2016 | BRL 21.6m | — | 3.2% |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of Brazilian reais, except per-share amounts.
Questions about the net income of Iguatemi
- How much did Iguatemi earn in fiscal 2025?
- Iguatemi reported a net profit of BRL 582.5m for fiscal 2025. In fiscal 2024 it reported a net profit of BRL 399.8m.
- What is the net margin of Iguatemi?
- In fiscal 2025 its net profit was 39.2% of its revenue.
- What was the most profitable year for Iguatemi?
- Of its last 10 fiscal years, fiscal 2025, with BRL 582.5m.
- Where do the figures for Iguatemi come from?
- From the annual financial statements (DFP) that Iguatemi files with the CVM, the Brazilian securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual financial statements (DFP) that Iguatemi files with the CVM, the Brazilian securities regulator. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Iguatemi: the Iguatemi page · annual accounts · revenue · dividends paid.
More companies from Brazil and the rest of the region: Latin American stocks.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.